Platelet-vessel wall interactions in hemostasis: Implication of 5-hydroxytryptamine
- 1 December 1984
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 15 (5-6) , 627-635
- https://doi.org/10.1007/bf01966784
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserinEuropean Journal of Pharmacology, 1983
- Platelet activation by endogenous 5-hydroxytryptamine and histamine released by mast cell degranulation with compound 48/80 in the ratInflammation Research, 1983
- Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserinThrombosis Research, 1982
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- Pharmacological Control of Platelet and Red Blood Cell Function in the MicrocirculationJournal of Cardiovascular Pharmacology, 1981
- Aggregation of platelets in damaged vesselsPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1981
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Enhanced malondialdehyde formation in reserpinized rabbit blood plateletsThrombosis Research, 1979
- Mechanisms of hemostasisMicrovascular Research, 1968
- Measurement of spontaneous fibrinolytic activityJournal of Clinical Pathology, 1964